MarketInOut Stock Screener Log In | Sign Up
 

Serina Therapeutics Inc

NYSE • Healthcare • Biotechnology • Quote as of 10/23/2026
Serina Therapeutics Inc stock price and volume chart

Company Profile

IndustryBiotechnology
SectorHealthcare
ExchangeNYSE
Market Capitalization44.7 mln
Float12.40 mln
Earnings Date11/18/2026

Piotroski F-Score

3 / 9
Below average

Relative Strength

15 / 100
Significantly lagging

Debt / Equity

0.17
Very low leverage

ROE

-265
Deeply negative

ROA

-130
Deeply negative

Business Description

Founded in 2006 and headquartered in Huntsville, Alabama, Serina Therapeutics is a medical research company focused on developing new treatments for brain and nervous system conditions, including Parkinson's disease and chronic pain. The company's work centers on its proprietary POZ platform, which is used to improve how drugs are delivered in the body, reducing unwanted immune responses while enhancing effectiveness. Serina has several programs at various stages of development, ranging from early laboratory research to completed early-phase human trials.

Key Fundamentals

EPS-1.87
ROE-265
ROIC-786
ROA-130
Interest Cover-118
EBITDA, mln-20.49
EV / EBITDA-0.70
EV / EBIT-0.69
Revenue, mln0.13
EV / Revenue110

Quote Details

Last 1.65
Change -0.11 (-6.25%)
Open 1.73
Volume 8,001
Turnover 13,202
Average Volume 31,469

Financial Ratios

Leverage Ratio1.38
Current Ratio6.65
Price / Book2.74
Price / Tangible Book2.74
Debt / Equity0.17
Price / Sales156

Financial Strength

Piotroski F-Score 3 / 9
Short Ratio0.57
Short % of Float0.26

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week -4.07% 19 / 100   
1 Month -22.9% 16 / 100   
2 Months -24.31% 20 / 100   
6 Months -16.24% 29 / 100   
1 Year -68.09% 12 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Blog